NM_000064.4(C3):c.3647-13A>G AND multiple conditions

Germline classification:: Likely benign (1 submission)
Last evaluated:: Oct 29, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002501717.1

Allele description [Variation Report for NM_000064.4(C3):c.3647-13A>G]

NM_000064.4(C3):c.3647-13A>G

Gene:

C3:complement C3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

19p13.3

Genomic location:

Preferred name:

NM_000064.4(C3):c.3647-13A>G

HGVS:

NC_000019.10:g.6686300T>C
NG_009557.1:g.39352A>G
NM_000064.4:c.3647-13A>GMANE SELECT
LRG_27:g.39352A>G
NC_000019.9:g.6686311T>C

Links:

dbSNP: rs760807491

NCBI 1000 Genomes Browser:

rs760807491

Molecular consequence:

NM_000064.4:c.3647-13A>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Age related macular degeneration 9
Identifiers:: MONDO: MONDO:0012659; MedGen: C1969651; OMIM: 611378

Name:: Atypical hemolytic-uremic syndrome with C3 anomaly
Synonyms:: AHUS, SUSCEPTIBILITY TO, 5; Atypical hemolytic-uremic syndrome 5
Identifiers:: MONDO: MONDO:0013043; MedGen: C2752037; Orphanet: 2134; OMIM: 612925

Name:: Complement component 3 deficiency
Synonyms:: Complement component 3 deficiency, autosomal recessive
Identifiers:: MONDO: MONDO:0013417; MedGen: C3151071; Orphanet: 280133; OMIM: 613779

Recent activity

Clear Turn Off Turn On

cytochrome b, partial (mitochondrion) [Oreohelix variabilis]
cytochrome b, partial (mitochondrion) [Oreohelix variabilis]
gi|1444586333|gb|AXL05286.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002806344	Fulgent Genetics, Fulgent Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely benign (Oct 29, 2021)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002806344

Fulgent Genetics, Fulgent Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely benign
(Oct 29, 2021)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002806344.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine